RNA Modifications: Bridging Biological Function and Therapeutic Potential

Mar 09–12, 2026 | Keystone Resort, Keystone, CO, United States
Scientific Organizers: Michaela Frye, Schraga Schwartz, Yunsun Nam, and Eckhard Jankowsky

  In Person
  On Demand
 Add to Calendar
×

-

Mar 09–12, 2026 | Keystone Resort, Keystone, CO, United States

Scientific Organizers: Michaela Frye, Schraga Schwartz, Yunsun Nam, and Eckhard Jankowsky

Supported by the  Directors' Fund

***Meeting program subject to change.

Available Formats:   = In Person     = On Demand
Monday, March 9, 2026
Registration
4:00–8:00 PM
Welcome Mixer
6:00–8:00 PM
Tuesday, March 10, 2026
Poster Setup
12:15–1:00 PM
On Own for Lunch
12:15–5:00 PM
Breakfast
7:00–8:00 AM
Welcome and Keynote Address
8:00–9:00 AM
Tsutomu Suzuki, University of Tokyo
Expanding Chemical Space of RNA Modifications
Molecular Mechanisms of RNA Modifications
9:00–11:15 AM
Caroline Köhrer, Alltrna
tRNA Therapeutics
Yunsun Nam, University of Texas Southwestern Medical Center
Structure and Function of RNA Modifying Protein
Sara H. Rouhanifard, Northeastern University
RNA Modifications on the Single Molecular Level and Spatial Transcriptomics
Short Talk(s) Chosen from Abstracts
Coffee Break
9:30–9:50 AM
Meet the Editors
11:15–12:15 PM
Poster Viewing
1:00–10:00 PM
Symposia Spotlight 1: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Short Talk(s) Chosen from Abstracts
Coffee Available
4:30–5:00 PM
Language Models Predicting RNA Modifications and Functions
5:00–7:00 PM
Schraga Schwartz, Weizmann Institute of Science
Computational and Functional Analyses of Modifications
Prashant Mali, University of California, San Diego
Transcriptome Engineering Toolsets
Eduardo Eyras, EMBL Australia, Australian National University
Machine Learning to Study Transcriptomes and Epitranscriptomes in RNA Biology and Cancer.
Short Talk(s) Chosen from Abstracts
Social Hour with Dinner
7:00–8:00 PM
Posters
7:30–10:00 PM
Wednesday, March 11, 2026
Breakfast
7:00–8:00 AM
RNA Therapeutics
8:00–11:00 AM
Peter C. Dedon, Massachusetts Institute of Technology
High Throughput Platforms for Epitranscriptomic Drug Discovery
Olivier Duss, European Molecular Biology Laboratory
Dynamic RNA Biology at the Single-Molecule Level: Watching how Interconnected Processes Work in Real-Time
Eckhard Jankowsky, Moderna
Biogenesis and Function of RNA Modifications
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
Poster Setup
11:00–1:00 PM
On Own for Lunch
11:00–5:00 PM
Poster Viewing
1:00–10:00 PM
Career Roundtable
1:45–3:15 PM
Panel Discussion: Science Meets Industry
3:30–4:30 PM
Coffee Available
4:30–5:00 PM
RNA Modifications in Diseases I
5:00–7:00 PM
Samie Jaffrey, Weill Medical College of Cornell University
Cap Modifications in Healthy Cells and Disease
Jordan L Meier, National Cancer Institute
Cytidine Acetylation across the Tree of Life
Michaela Frye, Deutsches Krebsforschungszentrum
tRNA Modifications in Cancer
Short Talk(s) Chosen from Abstracts
Social Hour with Dinner
7:00–8:00 PM
Posters
7:30–10:00 PM
Thursday, March 12, 2026
Breakfast
7:00–8:00 AM
RNA Engineering and Editing Approaches
8:00–11:00 AM
Namita Bisaria, AIRNA
Therapeutics based on ADAR -Base Editing
Nicole Martinez, Stanford University
RNA Modifications and Pre-mRNA Processing
Kate Meyer, Duke University
Genetically Encoded Tools for Studying mRNA Methylation
Jin Billy Li, Stanford University
RNA Editing and Sensing as a Common Mechanism Underlying the Genetic Risk of Inflammation
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
On Own for Lunch
12:00–5:00 PM
Symposia Spotlight 2: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Short Talk(s) Chosen from Abstracts
Coffee Available
4:30–5:00 PM
RNA Modifications Diseases II
5:00–6:45 PM
Zoya Ignatova, University of Hamburg
tRNA Engineering to Suppress Nonsense Mutations in Disease
Victoria H. Cowling, Cancer Research UK Scotland Institute
RNA Cap Modifications in T Cell Function
Chuan He, University of Chicago
RNA Modifications in Physiology and Immune-Related Disease
Short Talk(s) Chosen from Abstracts
Muthiah Manoharan, Alnylam Pharmaceuticals, Inc.
siRNA Therapeutics
Closing Keynote Address
6:45–7:30 PM
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
7:30–7:45 PM
Social Hour with Dinner
7:45–8:45 PM
Cash Bar
8:00–11:00 PM
Entertainment
8:00–11:00 PM
Friday, March 13, 2026
Departure
12:00–11:59 PM

Subscribe for Updates